Efficacy of Freeze-Dried Amnion Grafts on Cytokines in Uterine Exudates Following Hysteroscopic Adhesiolysis of Severe Intrauterine Adhesions

Abstract

Background Intrauterine adhesions (IUAs) are a benign uterine disorder that results in intrauterine adhesions and scarring. This study was conducted to assess the effects of freeze-dried amnion grafts on the concentrations of adhesion-related cytokines in uterine exudates following hysteroscopic adhesiolysis of IUAs. Materials and Methods This study was a prospective randomized controlled trial. Thirty patients who underwent hysteroscopic adhesiolysis for severe IUAs were enrolled. They were randomly divided into a study group (with freeze-dried amnion graft treatment after surgery, N = 15) and a control group (without a graft, N = 15). After complete separation of adhesions, a Foley balloon containing a freeze-dried amnion graft was inserted into the uterine cavity in the study group, while a Foley balloon with no graft was placed in the control group. Enzyme-linked immunosorbent assays were performed to test adhesion-related cytokine concentrations in uterine exudates, including IL-1β, TNF-α, and VEGF, at different time intervals after surgery. Second-look hysteroscopy was conducted three months after the surgery. On the basis of the American Fertility Society (AFS) scoring system, the level of adhesions was evaluated during hysteroscopy. Results The postoperative volume of the uterine exudates in the study group was significantly lower than that of the control group ( P < 0.05). The adhesion-related cytokine concentrations of TNF-α, VEGF, and IL-1β significantly increased after surgery in both groups. Their concentrations were significantly lower in the study group than in the control group ( P < 0.05). Moreover, IL-1β exhibited a long-lasting effect in the study group. AFS scores and readhesion rates were significantly lower in the study group than in the control group after hysteroscopic adhesiolysis of severe IUAs. Conclusion The application of freeze-dried amnion grafts is beneficial to the postoperative recovery of patients with severe IUAs and may reduce the readhesion rate after hysteroscopic adhesiolysis by lowering adhesion-related cytokines, including TNF-α, VEGF, and IL-1β.

Evaluation of the Effect of an Amniotic Membrane Derived Bio-Nano Product (LifeCell) on Human Endometrial Cells Proliferation and Gene Expression: An in-vitro Study

“…AM has been studied as a regenerative material for skin [13] and has demonstrated safety, effectiveness, and applicability in improving and healing wounds in internal organs [14]. Some applications of AM grafting have been reported in improving Asherman's syndrome [18] and reducing cytokine adhesions following its placement after Asherman's treatment, leading to overall improvement in treatment outcomes [19]. LifeCell is a product derived from AM and is available in various forms such as patches, solutions, and creams.…”

Proinflammatory cytokines in peritoneal fluid in women with peritoneal adhesions

“…На сьогодні відомо біля 100 БАР (медіаторів запалення, цитокінів, інтерлейкінів, інтерферонів) [14][15][16][17]. Провідна роль у регуляції активності і синхронізації дії імунокомпетентних клітин належить розчинним чинникам міжклітинної взаємодії -цитокінам.…”